Radleys, a supplier of affordable parallel synthesis and laboratory reactor products, has announced the appointment of Martyn Deal to the position of research and development manager
Martyn Deal, formerly of GSK, brings to the company 23 years experience and expertise in medicinal chemistry and technology development.
Commenting on the appointment Mark Radley (managing director) said "Martyn's track record of designing innovative new products for medicinal chemists is well proven, his recruitment represents a further investment in the future of our company.
"Over the last ten years, Radleys has, working with leading industrial and academic partners, established an international reputation for taking technological advances and turning them into problem solving new products" said Martyn Deal.
"I look forward to contributing to and managing the R+D and new product development processes at Radleys".
Radleys also announced that it had recently entered into a Knowledge Transfer Partnership with Anglia Ruskin University (Chelmsford, UK) and the UK Department of Trade and Industry (DTi).
Under the terms of the KTP - the university will provide technical support and access to proprietary knowledge to Radleys which in turn has taken on a new mechanical engineer to run the KTP project.
Mark Radley said: "We welcome scientists approaching us with their new product ideas; we are well versed in realising the commercial and scientific potential of technological advances".
Radleys says it is the market leader for low cost parallel chemistry tools, offering an unrivalled range of affordable synthesisers, evaporation and work-up systems to aid productivity of chemists from industry to academia.
